Simply Wall St report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Why ASPI Stock dropped -5.16% Today — RQD Quant Desk Flash
ASP Isotopes Inc. (ASPI) carries a Roarable Rating of E (Strong Sell) with 21/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is ASPI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, ASP Isotopes Inc. (NASDAQ: ASPI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 21/100 at a spot price of $2.02 (-5.16% 1D, market cap $326.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, ASPI ranks #261 in composite RQD confidence.
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does ASPI compare to OEC and NL in the Materials sector?
▼
Within the Materials sector (Major Chemicals), ASPI carries a Roarable E (21/100 RQD), trailing P/E of N/A, gross margin of 14.3%, and ROIC of -35.0%. By comparison, OEC (Orion S.A.) holds a D- grade (39/100 RQD, P/E N/A, ROIC 2.2%, cap $313.1M) and NL (NLI Holdings Inc.) posts a D grade (45/100 RQD, P/E N/A, ROIC 3.4%, cap $341.8M). Among the 5-stock peer group, ASPI leads on earnings multiple (N/A) while NL leads on capital efficiency (3.4% ROIC).
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for ASPI?
▼
Per ASPI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001921865), ASP Isotopes Inc. generated $23.8M in revenue (+475.5% YoY), -$159.8M in net income, and -$47.4M in free cash flow against $498.0M in total assets and $1.5M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 14.3% Gross Margin
Altman Z-Score 0.72 (DISTRESS RISK (<1.8)) • Piotroski F-Score 4/9
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
⚔️ Adversarial Opposing Case: What Could Spark a ASPI Turnaround Squeeze
While ASPI currently carries a cautious 21/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Materials with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.94) and Max Pain ($2.12) forces dealer call-delta covering toward $11.30.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Why ASPI Stock dropped -5.16% Today — RQD Quant Desk Flash
ASP Isotopes Inc. (ASPI) dropped -5.16% to $2.02, trading at 2% of its 52-week range ($1.89 – $10.76). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($1.89 – $10.76) with RSI-14 at 39.4 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $2.02 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 14.3% gross margin and $0 annual free cash flow.
Stock Titan report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
TradingView report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Kalkine Media report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
ASP Isotopes (NASDAQ:ASPI) CEO Paul Mann outlined the company’s plans to expand its isotope-enrichment, radiopharmacy and helium businesses, while targeting more than $300 million in EBITDA by 2031. Speaking at the Emerg
MIAMI, Oct. 27, 2026 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 97th Emerging Growth Conference on October 28 & 29, 2026. The Emerging Growth Confere
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring ASPI)
- ✓Walkthrough of ASPI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
ASPI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on ASPI today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for ASPI. Explore sector supply chains on /butterfly.
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (ASPI)
1. Head-to-Head Materials Peer Comparison (ASPI vs. OEC, NL, GEVO, SLI)
Industry: Major Chemicals (67 Tracked Issuers)Across 270 tracked Materials securities in the Roarable RQD universe, ASP Isotopes Inc. (ASPI) ranks #261 by composite RQD confidence (21/100, grade E) and #197 by equity capitalization ($326.5M). Within this direct 5-issuer industry benchmark cohort, ASPI leads on earnings valuation at N/A trailing P/E, while NL leads on capital efficiency and profitability with 3.4% ROIC and 30.4% gross margin. NL currently holds the highest overall quantitative score in the immediate peer group at 45/100 (D) compared with ASPI at 21/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| ASPI
ACTIVE
ASP Isotopes Inc. | E | 21/100 | — | 14.3% | -35.0% | -5.16% | $326.5M | Benchmark Subject |
| OEC Orion S.A. | D- | 39/100 | — | 19.9% | 2.2% | +1.08% | $313.1M | /oec-vs-aspi → |
| NL NLI Holdings Inc. | D | 45/100 | — | 30.4% | 3.4% | +1.72% | $341.8M | /nl-vs-aspi → |
| GEVO Gevo Inc. | E | 24/100 | — | — | -2.9% | +3.31% | $299.2M | /gevo-vs-aspi → |
| SLI Standard Lithium Ltd. | D | 45/100 | — | — | — | -0.69% | $358.0M | /sli-vs-aspi → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001921865In its most recent audited fiscal period (FY2025, filed 2025-12-31), ASP Isotopes Inc. (ASPI) reported GAAP revenue of $23.8M (+475.5% vs. FY2024 revenue of $4.1M , and +5407.5% cumulative change since FY2023) , GAAP net income of -$159.8M, operating cash flow of -$37.8M, and free cash flow of -$47.4M (-79.9% YoY). On the balance sheet, ASPI closed FY2025 with $498.0M in total assets against $1.5M in total debt (Altman Z-Score: 0.72, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $23.8M | -$159.8M | -$37.8M | -$47.4M | $498.0M | $1.5M |
| FY2024 (FY) | 2024-12-31 | $4.1M | -$32.4M | -$16.7M | -$26.4M | $94.3M | $1.4M |
| FY2023 (FY) | 2023-12-31 | $433.0K | -$16.3M | -$5.4M | -$5.4M | — | — |
3. ASPI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs ASPI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, ASP Isotopes Inc. (NASDAQ: ASPI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 21/100 at a spot price of $2.02 (-5.16% 1D, market cap $326.5M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 3/20, Executive Insider Alignment 5/20, FRED Macro Regime Fit 5/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, ASPI ranks #261 in composite RQD confidence.
How does ASPI compare to OEC and NL in the Materials sector?
Within the Materials sector (Major Chemicals), ASPI carries a Roarable E (21/100 RQD), trailing P/E of N/A, gross margin of 14.3%, and ROIC of -35.0%. By comparison, OEC (Orion S.A.) holds a D- grade (39/100 RQD, P/E N/A, ROIC 2.2%, cap $313.1M) and NL (NLI Holdings Inc.) posts a D grade (45/100 RQD, P/E N/A, ROIC 3.4%, cap $341.8M). Among the 5-stock peer group, ASPI leads on earnings multiple (N/A) while NL leads on capital efficiency (3.4% ROIC).
What are the biggest fundamental strengths and SEC risk factors for ASPI?
Per ASPI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001921865), ASP Isotopes Inc. generated $23.8M in revenue (+475.5% YoY), -$159.8M in net income, and -$47.4M in free cash flow against $498.0M in total assets and $1.5M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is ASPI trading relative to its 50-day, 200-day, and 52-week technical levels?
ASPI last traded at $2.02 (-5.16% on volume of 3,437,769 shares), positioning the stock -31.29% below its 50-day simple moving average ($2.94) and -58.18% below its 200-day simple moving average ($4.83). Across its 52-week range of $1.89 to $10.76, ASPI sits at the 1.5% percentile with a 14-day RSI of 39.4 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.77 to $2.27).
ASPI Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ASPI stock moving today?
Why ASPI Stock dropped -5.16% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
ASPI — ASP Isotopes Inc.: What the Facts Mean to a Prospective Investor
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, ASPI carries an RQD Score of 21 out of 100, a letter grade of E, and the verdict label "Roarable Strong Sell — Forensic Risk / Avoid." Each of the five pillars is scored out of 20. The Fundamental Cash Engine scores 5 / 20, reflecting ROIC of -35% and an FCF yield of -14.53%, meaning the business is consuming cash relative to its value rather than generating it. Whale 13F Flow scores 3 / 20 for institutional accumulation and options positioning, the weakest institutional signal in the set. Insider Conviction scores 3 / 20 based on SEC Form 4 and Congressional PTR cluster flow. Macro Regime Fit scores 5 / 20 with a Beta of 1.0 and noted sector sensitivity. Forensic Balance Sheet scores 5 / 20, driven by an Altman Z-Score of 0.72, a Piotroski F-Score of 4/9, and a Debt/Equity ratio of 0.01.
For a prospective investor evaluating the stock today, the upside case rests on the company's reported cash position, which per the SEC financials was $279.6M at FY 2025, against total debt of $1.5M. That liquidity is the main offset to the negative cash-flow figures. The valuation tradeoff is steep: per the market data, the stock trades at $2.13 against a 52-week range of $1.89 to $10.76, and P/E-based valuation cannot be assessed because earnings per share and P/E are not available in source data. The rating indicates that the forensic and cash-generation indicators weigh heavily against the stock, and the institutional and insider signals provide little offsetting support.
Business
ASP Isotopes Inc. (ASPI) is a NASDAQ-listed issuer classified in the Materials sector and the Major Chemicals industry, with a market capitalization of $0.3B per the profile. Per the SEC financials, FY 2025 revenue was $23.8M, with reported gross margin of 14.3% per the market data. Customer identity, product mix, and specific revenue-generation mechanics are not available in source data beyond the sector and industry classification.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $23.8M | $-59.9M | $-159.8M | N/A | $-47.4M | $279.6M | $1.5M |
| FY 2024 | $4.1M | $-26.4M | $-32.4M | N/A | $-26.4M | $61.9M | $1.4M |
| FY 2023 | $0.4M | $-16.0M | $-16.3M | N/A | $-5.4M | N/A | N/A |
Per the market data, operating margin and net margin were each -60%, and ROIC was -35%. Per the Roarable RQD rating, the Altman Z-Score is 0.72 and the Piotroski F-Score is 4/9, both of which point to financial distress indicators. Debt/Equity is 0.01 per the rating, and reported debt was $1.5M against $279.6M of cash at FY 2025, indicating a balance sheet with minimal leverage but deeply negative operating results.
Recent Catalysts & News Wire Analysis
Per the recent news data, the wire contains six items, all dated in the most recent window and all flagged YELLOW under the MARKET WIRE impact label. The first item is a Simply Wall St forecast and analyst-predictions piece covering market action and institutional positioning. The second reports that the COO sold 22,500 shares under a trading plan to cover stock-award taxes, per a Stock Titan headline. The third, from Seeking Alpha, reports that a South Africa gas project achieved stable liquid helium production. The fourth, from TradingView, is an estimates page. The fifth, from Stock Titan, reports that a South African nuclear fuel project has secured a buyer, TerraPower. The sixth is a Kalkine Media piece questioning whether the company can build on stable liquid helium output. Risk watch items include the insider sale disclosed in the wire and the continued negative cash flow shown in the SEC financials. Per the Butterfly Supply-Chain Graph, the supply chain is recorded as NONE, with no butterfly links and no proprietary signals.
Open Questions
- What drives the gap between the FY 2025 net loss of $-159.8M and the operating loss of $-59.9M, and does it recur?
- What are the current P/E, EPS, and EV/EBITDA figures, given that all valuation multiples are unavailable?
- What portion of the $279.6M cash position is committed to operations versus available for distribution or reinvestment?
- What is the mechanism behind the TerraPower buyer headline, and what revenue or timing is attached to it?
- What institutional and Congressional holdings exist, given that holder data is unavailable in source data?
ASPI Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for ASP Isotopes Inc. (ASPI) • Click "Debate This Headline" to argue it in the Roar Pit below
Simply Wall St report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Seeking Alpha report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
TradingView report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Kalkine Media report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Stock Titan report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
Simply Wall St report covering ASP Isotopes Inc. (ASPI) market action, institutional positioning, and fundamental catalysts.
ASPI Bull vs. Bear Conversation Board — What's Your Call at $2.02?
🔥 Official Bull vs. Bear Debate: Is ASPI (E • RQD 21/100) a Buy at $2.13?
Welcome to the ASPI (ASP Isotopes Inc.) Roar Pit. Current RQD Composite is 21/100 (Roarable Strong Sell — Forensic Risk / Avoid) in Major Chemicals. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
Pump the brakes on ASPI — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on ASPI, but look at what you are paying: current EV/EBITDA multiples with 14.3% gross margins. Unless ASP Isotopes Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
ASPI cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on ASPI, the market is fixating on short-term headline noise in Major Chemicals and ignoring the balance sheet and cash flow trajectory. At $2.13 (52-wk range $1.89 - $10.76), any beat on forward guidance forces shorts and underweight funds to chase.